2026-526659-70-00Not yet recruitingPhase 1
A Study of PRO-203 in Healthy Volunteers and Participants with Systemic Sclerosis
Source: EU CTIS (euclinicaltrials.eu) · Last updated 30 Sept 2026
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 9 (estimated)
- First submitted
- 18 Jun 2026
- Start date
- 3 Aug 2026
- Lead sponsor
- Prolium Bioscience Inc.
- Diseases
- Systemic sclerosis (scleroderma)
- EU CT number
- 2026-526659-70-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 9
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (5)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitaetsklinikum Duesseldorf AöR | Duesseldorf | Germany | Not yet recruiting |
| Fraunhofer Institute For Translational Medicine And Pharmacology ITMP | Frankfurt Am Main | Germany | Not yet recruiting |
| Universitaetsklinikum Jena KöR | Jena | Germany | Not yet recruiting |
| Universitaetsklinikum Schleswig-Holstein AöR | Luebeck | Germany | Not yet recruiting |
| LMU Klinikum Muenchen AöR | Munich | Germany | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.